Assetmark Inc. Boosts Stock Position in The Cooper Companies, Inc. $COO

Key Points

• Assetmark Inc. increased its stake in The Cooper Companies (NASDAQ:COO) by 21% in Q4, adding 31,980 shares to hold 184,410 shares worth about $15.11 million (≈0.09% of the company).
• Cooper beat Q1 estimates with $1.10 EPS (vs. $1.03 consensus) and $1.02 billion revenue (up 6.2% YoY), and set Q2 2026 guidance of $4.58–$4.66 EPS.
• Analyst sentiment is broadly positive with an average rating of "Moderate Buy" and an average target of $90.79, though targets vary from Citigroup's $87 (neutral) to Barclays' $103 (overweight).

Assetmark Inc. grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 21.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 184,410 shares of the medical device company's stock after purchasing an additional 31,980 shares during the period. Assetmark Inc. owned about 0.09% of Cooper Companies worth $15,114,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company's stock valued at $1,890,000 after buying an additional 7,363 shares during the period. First Trust Advisors LP increased its holdings in Cooper Companies by 115.8% during the second quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company's stock valued at $9,702,000 after buying an additional 73,165 shares during the period. Cresset Asset Management LLC purchased a new position in Cooper Companies during the second quarter valued at approximately $291,000. Cerity Partners LLC increased its holdings in Cooper Companies by 4.4% during the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company's stock valued at $1,272,000 after buying an additional 757 shares during the period. Finally, Daiwa Securities Group Inc. raised its stake in Cooper Companies by 2.8% in the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company's stock worth $2,551,000 after buying an additional 973 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Trading Down 1.3%

NASDAQ:COO opened at $69.38 on Friday. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $89.83. The firm has a fifty day simple moving average of $75.93 and a 200-day simple moving average of $76.46. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $13.54 billion, a P/E ratio of 34.35, a PEG ratio of 1.81 and a beta of 1.07.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.07. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The firm's revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

COO has been the subject of a number of analyst reports. Citigroup lowered their target price on Cooper Companies from $88.00 to $87.00 and set a "neutral" rating for the company in a report on Friday, March 6th. Weiss Ratings raised Cooper Companies from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Monday, January 12th. Wall Street Zen upgraded Cooper Companies from a "hold" rating to a "buy" rating in a research note on Saturday, February 28th. William Blair upgraded Cooper Companies to a "strong-buy" rating in a research note on Friday, January 30th. Finally, Barclays boosted their target price on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, March 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $90.79.

Cooper Companies Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.